UOC
ORTX

UBS O'Connor’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

UBS O'Connor’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-71,010
Closed -$551K – 634
2023
Q3 		$551K Hold
71,010
– – 0.01% 394
2023
Q2 		$369K Buy
71,010
+3,498
+5% +$17.8K 0.01% 463
2023
Q1 		$363K Buy
+67,512
New +$367K 0.01% 489
2022
Q4 		– Sell
-43,298
Closed -$216K – 517
2022
Q3 		$216K Sell
43,298
-66,094
-60% -$368K ﹤0.01% 845
2022
Q2 		$639K Buy
+109,392
New +$617K 0.01% 798

Other funds holding ORTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

UBS O'Connor's ORTX Position: Q4 2023 in Review

UBS O'Connor sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2023, closing a stake of 71,010 shares — an estimated $551K sold.

UBS O'Connor first reported a position in ORTX in Q2 2022 and held it in 5 quarters. The position peaked at $639K in Q2 2022. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2023.

  • UBS O'Connor reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • UBS O'Connor sold 71,010 Orchard Therapeutics plc American Depositary Shares shares in Q4 2023, an estimated $551K.
  • UBS O'Connor first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2022 and held it in 5 quarters.
  • UBS O'Connor's Orchard Therapeutics plc American Depositary Shares position peaked at $639K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.